These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Prescribing and monitoring clozapine in Christchurch. McKean A, Vella-Brincat J, Begg E. Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375 [Abstract] [Full Text] [Related]
27. Time to rehospitalization in patients with schizophrenia discharged on first generation antipsychotics, non-clozapine second generation antipsychotics, or clozapine. Werneck AP, Hallak JC, Nakano E, Elkis H. Psychiatry Res; 2011 Aug 15; 188(3):315-9. PubMed ID: 21596442 [Abstract] [Full Text] [Related]
28. [Relationships between insight and medication adherence in subjects with psychosis]. Droulout T, Liraud F, Verdoux H. Encephale; 2003 Aug 15; 29(5):430-7. PubMed ID: 14615692 [Abstract] [Full Text] [Related]
29. [Long-term clinical experience with clozapine]. Gelly F, Chambon O, Marie-Cardine M. Encephale; 1997 Aug 15; 23(5):385-96. PubMed ID: 9453932 [Abstract] [Full Text] [Related]
30. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics]. Geronimi-Ferret D, Lesay M, Barges-Bertocchio MH, Cornet-Bonnefont M, Robert H. Encephale; 1997 Sep 15; 23 Spec No 4():24-31. PubMed ID: 9417402 [Abstract] [Full Text] [Related]
31. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients. McKee JR, Wall T, Owensby J. Clin Schizophr Relat Psychoses; 2011 Apr 15; 5(1):26-32. PubMed ID: 21459736 [Abstract] [Full Text] [Related]
33. Reasons for discontinuing clozapine: A cohort study of patients commencing treatment. Legge SE, Hamshere M, Hayes RD, Downs J, O'Donovan MC, Owen MJ, Walters JTR, MacCabe JH. Schizophr Res; 2016 Jul 15; 174(1-3):113-119. PubMed ID: 27211516 [Abstract] [Full Text] [Related]
34. Delayed onset of clozapine-induced leucopenia. Nongpiur A, Praharaj SK, Sarkar S, Das B. Am J Ther; 2012 May 15; 19(3):e118-9. PubMed ID: 20724912 [Abstract] [Full Text] [Related]
35. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia. Ucok A, Yağcıoğlu EA, Yıldız M, Kaymak SU, Saka MC, Taşdelen R, Danacı AE, Şenol ŞH. Psychiatry Res; 2019 May 15; 275():149-154. PubMed ID: 30908979 [Abstract] [Full Text] [Related]
36. Clozapine treatment in patients with prior substance abuse. Kelly DL, Gale EA, Conley RR. Can J Psychiatry; 2003 Mar 15; 48(2):111-4. PubMed ID: 12655909 [Abstract] [Full Text] [Related]
37. The risk of suicide after clozapine discontinuation: Cause for concern. Patchan KM, Richardson C, Vyas G, Kelly DL. Ann Clin Psychiatry; 2015 Nov 15; 27(4):253-6. PubMed ID: 26554366 [Abstract] [Full Text] [Related]
38. Clozapine for substance-abusing schizophrenic patients. Tsuang JW, Eckman TE, Shaner A, Marder SR. Am J Psychiatry; 1999 Jul 15; 156(7):1119-20. PubMed ID: 10401473 [No Abstract] [Full Text] [Related]
39. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records. Ingimarsson O, MacCabe JH, Haraldsson M, Jónsdóttir H, Sigurdsson E. Nord J Psychiatry; 2016 Aug 15; 70(6):450-5. PubMed ID: 27049594 [Abstract] [Full Text] [Related]
40. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL. J Clin Psychiatry; 2007 Nov 15; 68(11):1751-62. PubMed ID: 18052569 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]